I got You got CD4+ T-cell! - What Type of Blood Cell are You? tryinteract.com/share/quiz/5e1…
So fun Kate Feder!!! Upcoming hematology super🌟
#mpnsm #leukemia #GoBlueMed

Hello all #ASH23 attendees-please consider this fantastic Friday ASH Satellite symposium for your agenda. Thanks to AA&MDSIF & Cleveland Clinic for this opportunity! Looking fwd to the program with fellow speakers Sudipto Mukherjee MD PhD MPH Abhay Singh Kristen Pettit & many others !…

Here is our top coverage from #SOHO23 with news from Daniel H Foley, MD Kristen Pettit Jason Westin, MD FACP Washington U. Med & more!

1. ow.ly/IWIR50PKFW7
2. ow.ly/Ufim50PKFWc
3. ow.ly/NuFU50PKFW0
4. ow.ly/CulX50PKFW3
5. ow.ly/Bz2h50PKFW4
6. ow.ly/xZB550PKFVZ

Upcoming CME opportunity on the latest in hematologic malignancies. Register: michmed.org/xNmnv #cme #hematology #myeloma #lymphoma #myeloproliferativeneoplasms #cartcell #leukemia

At #SOHO23 , experts discussed the shift in the therapeutic landscape for #MPNs toward a goal of meaningful disease modification. #mpnsm | Daniel H Foley, MD Kristen Pettit Society of Hematologic Oncology (SOHO)

Read more: ow.ly/cWGI50PImrH

Upcoming CME opportunity on the latest in hematologic malignancies. Register: michmed.org/xNmnv #cme #hematology #myeloma #lymphoma #myeloproliferativeneoplasms #cartcell #leukemia

Check out outcomes of our approach for ALL using individualized pegasparaginase dosing & monitoring! 🎉 Proud of Taylor Coe-Eisenberg and #teambadblood Bernie Marini Anthony Perissinotti Kristen Pettit and twitterless Patrick Burke and Dale Bixby! rb.gy/0hva3

The field of #BPDCN is rapidly evolving | Our new article by Dr. Pemmaraju Naveen Pemmaraju, MD highlights the new era of targeting #CD123 in combinations & beyond
MD Anderson Cancer Center Clin Adv Hem Onc

pubmed.ncbi.nlm.nih.gov/37145496/

Kristen Pettit kudos for great MPN updates for colleagues in Mediterranean #ASH22 updates . Several great speakers lined up ASH Toyosi Odenike Nitin Jain Geoffrey Uy Ann LaCasce, MD

MPN Education Session starting soon waaaay at the far end of the convention center…Get your steps in and come learn about current issues in MPNs! #ASH22

Episode 8 is here! We chat with leukemia expert Dr. Dale Bixby about FLT3+ AML. Listen for a lively, possibly heretical discussion! 🩸🏒 Bernie Marini Anthony Perissinotti
anchor.fm/wolverheme/epi…

Let's talk about bone marrow fibrosis in myelofibrosis.

When we hear fibrosis, we think lung (IPF) or liver (cirrhosis), devastating conditions.
The beauty about marrow fibrosis: it's reversible with allogeneic BMT.

Let's start🧵with new #ASH22 abstracts

#mpnsm #MedTwitter /19

❔ There are now 6 TKIs for #CML —but which to choose first? Read the #ASCOEdBook review by Drs. Kristen Pettit, @a_razzle, Ehab L. Atallah & Jerald Radich: fal.cn/3t5cH #ASCO22 #MPNSM

How do you treat patients with R/R Ph- ALL in first salvage? Check out our latest multicenter collab comparing outcomes with chemo vs novel therapy 👇

tandfonline.com/doi/full/10.10…

I’m excited to introduce our brand new hematology podcast – WolverHeme Happy Hour (@wolverheme anchor.fm/wolverheme)! Grab your favorite drink🍻and listen to me, Anthony Perissinotti, and friends nerd out about heme data! open.spotify.com/show/3VDDwc3BE… #TwitteRx #WolverHeme

Pacritinib approved for patients with MF and platelets <50k. Great to have a new tool to use in this tough setting! #mpnsm

I crack myself up 🤣

👀Check out our newest paper on antibiotic de-escalation in AML pts w/ FN! jnccn.org/view/journals/…

Our protocol (started in 2017) resulted in:
- Reduced anti-pseudomonal beta-lactam use by median 11 DAYS
- Significantly ⬇️ CDI
- No negative impact on clinical outcomes

Great news for #mpnsm patients! It has been a long road of development for momelotinib, but it will be nice to have this as an option for our cytopenic MF patients. Naveen Pemmaraju, MD Stephen Oh Ruben A. Mesa, MD Raajit Rampal, M.D.Ph.D. Tania Jain Aaron Gerds MD, MS Rami komrokji Prithviraj Bose Kristen Pettit

Michigan set to get COVID booster shot as a team espn.com/college-footba…